Scalper1 News
United Therapeutics (UTHR) scored a legal victory over Sandoz in a 2-year-old patent case that will likely provide additional legal protection for United’s Remodulin drug, which treats breathing problems for people with arterial hypertension. United Therapeutics stock soared to an all-time of 118 on the victory. In midday trading in the stock market today, United Therapeutics was up nearly 26%, near 115.50. In an email to client Friday, ISI Group Scalper1 News
Scalper1 News